CBD Global Sciences Kiemelkedően
Mi az CBD Global Sciences Kiemelkedően?
A Kiemelkedően az CBD Global Sciences Inc. - 34.526M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a OTC-on cégekben a CBD Global Sciences -hoz képest
Mit csinál CBD Global Sciences?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
kiemelkedően -hoz hasonló cégek CBD Global Sciences
- Thunder Bridge Acquisition II Ltd nak Kiemelkedően 34.500M van
- Battery Future Acquisition Corp nak Kiemelkedően 34.500M van
- Concord Acquisition Corp III nak Kiemelkedően 34.500M van
- Falcon Capital Acquisition nak Kiemelkedően 34.500M van
- Zevra Therapeutics Inc nak Kiemelkedően 34.505M van
- Tredegar nak Kiemelkedően 34.511M van
- CBD Global Sciences nak Kiemelkedően 34.526M van
- Caesarstone Ltd nak Kiemelkedően 34.532M van
- YDx Innovation nak Kiemelkedően 34.542M van
- American Renal Associates nak Kiemelkedően 34.543M van
- Silver Bull Resources nak Kiemelkedően 34.548M van
- Natus Medical Inc nak Kiemelkedően 34.581M van
- Goldstone Technologies nak Kiemelkedően 34.582M van